The Clorox Company
CLX
$138.78
$0.510.37%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -1.98% | 6.17% | -4.01% | 0.53% | 3.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.98% | 6.17% | -4.01% | 0.53% | 3.47% |
| Cost of Revenue | -6.05% | -1.69% | -10.17% | -6.59% | -6.02% |
| Gross Profit | 3.61% | 17.89% | 5.51% | 12.24% | 20.14% |
| SG&A Expenses | -7.46% | -3.37% | -5.57% | 7.57% | 16.01% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 345.24% | 585.71% | 565.63% | 40.91% | 75.00% |
| Total Operating Expenses | -4.18% | 0.32% | -6.01% | -2.29% | 0.41% |
| Operating Income | 13.32% | 56.71% | 12.18% | 25.83% | 31.42% |
| Income Before Tax | 312.10% | 261.59% | 67.23% | 176.92% | -72.70% |
| Income Tax Expenses | 179.69% | 238.46% | 37.66% | 134.78% | -50.77% |
| Earnings from Continuing Operations | 403.23% | 273.74% | 81.37% | 200.00% | -79.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 15.38% | 0.00% | 0.00% | -20.00% | -30.00% |
| Net Income | 471.25% | 315.12% | 87.92% | 224.32% | -81.61% |
| EBIT | 13.32% | 56.71% | 12.18% | 25.83% | 31.42% |
| EBITDA | 9.25% | 41.73% | 9.43% | 20.25% | 24.97% |
| EPS Basic | 474.73% | 314.50% | 86.94% | 220.90% | -81.82% |
| Normalized Basic EPS | 17.82% | 64.46% | 12.56% | 29.82% | 35.02% |
| EPS Diluted | 487.33% | 325.33% | 88.86% | 225.98% | -82.26% |
| Normalized Diluted EPS | 17.63% | 64.34% | 12.59% | 29.70% | 35.17% |
| Average Basic Shares Outstanding | 0.10% | 0.31% | 0.47% | 0.50% | 0.47% |
| Average Diluted Shares Outstanding | 0.22% | 0.34% | 0.48% | 0.57% | 0.40% |
| Dividend Per Share | 1.67% | 1.68% | 1.69% | 1.69% | 1.70% |
| Payout Ratio | -0.82% | -0.76% | -0.46% | -0.69% | 4.56% |